Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven I. Sherman

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Transactions of the American Clinical and Climatological Association|September 14, 2019
EVOLUTION OF TARGETED THERAPIES FOR THYROID CARCINOMASteven I Sherman
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2011
Targeted therapies for thyroid tumorsSteven I Sherman
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Early clinical studies of novel therapies for thyroid cancersSteven I Sherman
Biochemical Pharmacology|May 18, 2010
Targeted therapy of thyroid cancerSteven I Sherman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 24, 2009
Molecularly targeted therapies for thyroid cancersSteven I Sherman
Oral Oncology|April 16, 2013
Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancerSteven I Sherman
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
Advances in chemotherapy of differentiated epithelial and medullary thyroid cancersSteven I Sherman
Lancet (London, England)|February 14, 2003
Thyroid carcinomaSteven I Sherman
Clinical Lymphoma|April 4, 2003
Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphomaSteven I Sherman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 26, 2013
The role of recombinant human thyrotropin for diagnostic monitoring of patients with differentiated thyroid cancerSteven I Sherman
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Transactions of the American Clinical and Climatological Association|September 14, 2019
EVOLUTION OF TARGETED THERAPIES FOR THYROID CARCINOMASteven I Sherman
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 2, 2011
Targeted therapies for thyroid tumorsSteven I Sherman
Endocrinology and Metabolism Clinics of North America|May 27, 2008
Early clinical studies of novel therapies for thyroid cancersSteven I Sherman
Biochemical Pharmacology|May 18, 2010
Targeted therapy of thyroid cancerSteven I Sherman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 24, 2009
Molecularly targeted therapies for thyroid cancersSteven I Sherman
Oral Oncology|April 16, 2013
Lessons learned and questions unanswered from use of multitargeted kinase inhibitors in medullary thyroid cancerSteven I Sherman
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
Advances in chemotherapy of differentiated epithelial and medullary thyroid cancersSteven I Sherman
Lancet (London, England)|February 14, 2003
Thyroid carcinomaSteven I Sherman
Clinical Lymphoma|April 4, 2003
Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphomaSteven I Sherman
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 26, 2013
The role of recombinant human thyrotropin for diagnostic monitoring of patients with differentiated thyroid cancerSteven I Sherman
Pageof 15